Lemaitre Vascular (LMAT) Misses Q1 EPS by 2c

Lemaitre Vascular (NASDAQ: LMAT) reported Q1 EPS of $0.13, $0.02 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $23.3 million versus the consensus estimate of $23.59 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Bill.com (BILL) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 Guidance
• Deere shares climb as fiscal Q3 earnings and revenue top estimates